Unknown

Dataset Information

0

Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC.


ABSTRACT:

Background

Bisphosphonate therapy has become a popular treatment for osteoporosis, Paget's disease, multiple myeloma, osteogenesis imperfecta, myocardial infarction, and cancer despite its serious side effects. Bisphosphonate-induced molecular signaling changes in cells are still not clearly elucidated.

Methods

As bisphosphonates are primarily engulfed by macrophages, we treated RAW 264.7 cells (a murine macrophage cell line) with pamidronate and investigated global protein expressional changes in cells by immunoprecipitation high performance liquid chromatography (IP-HPLC) using 218 antisera.

Results

Pamidronate upregulated proliferation-activating proteins associated with p53/Rb/E2F and Wnt/?-catenin pathways, but downregulated the downstream of RAS signaling, pAKT1/2/3, ERK-1, and p-ERK-1, and subsequently suppressed cMyc/MAX/MAD network. However, in situ proliferation index of pamidronate-treated RAW264.7 cells was slightly increased by 3.2% vs. non-treated controls. Pamidronate-treated cells showed increase in the expressions of histone- and DNA methylation-related proteins but decrease of protein translation-related proteins. NFkB signaling was also suppressed as indicated by the down-regulations of p38 and p-p38 and the up-regulation of mTOR, while the protein expressions related to cellular protection, HSP-70, NRF2, JNK-1, and LC3 were upregulated. Consequently, pamidronate downregulated the protein expressions related to immediate inflammation,cellular differentiation, survival, angiogenesis, and osteoclastogenesis, but upregulated PARP-1 and FAS-mediated apoptosis proteins. These observations suggest pamidronate affects global protein expressions in RAW 264.7 cells by stimulating cellular proliferation, protection, and apoptosis but suppressing immediate inflammation, differentiation, osteoclastogenesis, and angiogenesis. Accordingly, pamidronate appears to affect macrophages in several ways eliciting not only its therapeutic effects but also atypical epigenetic modification, protein translation, RAS and NFkB signalings. Therefore, our observations suggest pamidronate-induced protein expressions are dynamic, and the affected proteins should be monitored by IP-HPLC to achieve the therapeutic goals during treatment.

SUBMITTER: Lee SS 

PROVIDER: S-EPMC7246033 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC.

Lee Sang Shin SS   Kim Soung Min SM   Kim Yeon Sook YS   Lee Suk Keun SK  

PeerJ 20200521


<h4>Background</h4>Bisphosphonate therapy has become a popular treatment for osteoporosis, Paget's disease, multiple myeloma, osteogenesis imperfecta, myocardial infarction, and cancer despite its serious side effects. Bisphosphonate-induced molecular signaling changes in cells are still not clearly elucidated.<h4>Methods</h4>As bisphosphonates are primarily engulfed by macrophages, we treated RAW 264.7 cells (a murine macrophage cell line) with pamidronate and investigated global protein expres  ...[more]

Similar Datasets

| S-EPMC6308107 | biostudies-literature
| S-EPMC8956197 | biostudies-literature
| S-EPMC9405577 | biostudies-literature
| S-EPMC5471328 | biostudies-literature
| S-EPMC6934980 | biostudies-literature
| S-EPMC5943162 | biostudies-literature
| S-EPMC4331931 | biostudies-literature
2009-12-31 | GSE14612 | GEO
| S-EPMC4314132 | biostudies-literature
2009-12-30 | E-GEOD-14612 | biostudies-arrayexpress